{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T04:30:50Z","timestamp":1792989050655,"version":"4.5.0"},"reference-count":130,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG074541"],"award-info":[{"award-number":["R01AG074541"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007625","name":"Cure Alzheimer's Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016608","name":"Rainwater Charitable Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.neurot.2025.e00536","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T20:59:59Z","timestamp":1738357199000},"page":"e00536","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Identification and development of cGAS inhibitors and their uses to treat Alzheimer's disease"],"prefix":"10.1016","volume":"22","author":[{"given":"Jazmin","family":"Alarc\u00f3n-Esp\u00f3sito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi Kumar","family":"Nagiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhash C.","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurot.2025.e00536_bib1","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ijbiomac.2020.11.192","article-title":"Review on Alzheimer's disease: inhibition of amyloid beta and tau tangle formation","volume":"167","author":"Ashrafian","year":"2021","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.neurot.2025.e00536_bib2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41582-024-00940-4","article-title":"Is Alzheimer disease a disease?","volume":"20","author":"Korczyn","year":"2024","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.neurot.2025.e00536_bib3","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.4103\/1673-5374.386406","article-title":"Amyloid-beta and tau protein beyond Alzheimer\u2019s disease","volume":"19","author":"Abyadeh","year":"2024","journal-title":"Neural Regeneration Research"},{"key":"10.1016\/j.neurot.2025.e00536_bib4","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.neurobiolaging.2005.05.022","article-title":"Intraneuronal A\u03b2 accumulation and origin of plaques in Alzheimer's disease","volume":"26","author":"Gouras","year":"2005","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurot.2025.e00536_bib5","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00401-010-0679-9","article-title":"Intraneuronal \u03b2-amyloid accumulation and synapse pathology in Alzheimer's disease","volume":"119","author":"Gouras","year":"2010","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neurot.2025.e00536_bib6","first-page":"311","article-title":"Alzheimer's disease and the amyloid-\u03b2 peptide","volume":"19","author":"Murphy","year":"2010","journal-title":"J\u00a0Alzheim Dis"},{"key":"10.1016\/j.neurot.2025.e00536_bib7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40478-015-0199-x","article-title":"Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer\u2019s disease","volume":"3","author":"Pooler","year":"2015","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.neurot.2025.e00536_bib8","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","article-title":"Amyloid-\u03b2 and tau: the trigger and bullet in Alzheimer disease pathogenesis","volume":"71","author":"Bloom","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurot.2025.e00536_bib9","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1212\/WNL.42.3.631","article-title":"Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease","volume":"42","author":"Arriagada","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.neurot.2025.e00536_bib10","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1006\/exnr.2002.8014","article-title":"Tau conformational changes correspond to impairments of episodic memory in mild cognitive impairment and Alzheimer\u2019s disease","volume":"177","author":"Ghoshal","year":"2002","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neurot.2025.e00536_bib11","doi-asserted-by":"crossref","first-page":"4899","DOI":"10.1038\/s41467-022-32592-7","article-title":"Earlier Alzheimer\u2019s disease onset is associated with tau pathology in brain hub regions and facilitated tau spreading","volume":"13","author":"Frontzkowski","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.neurot.2025.e00536_bib12","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/brain\/aww027","article-title":"Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer\u2019s disease","volume":"139","author":"Ossenkoppele","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.neurot.2025.e00536_bib13","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","article-title":"PET imaging of tau deposition in the aging human brain","volume":"89","author":"Scholl","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.neurot.2025.e00536_bib14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/ana.25406","article-title":"Longitudinal tau accumulation and atrophy in aging and alzheimer disease","volume":"85","author":"Harrison","year":"2019","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurot.2025.e00536_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173554","article-title":"Alzheimer's disease: recent treatment strategies","volume":"887","author":"Vaz","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neurot.2025.e00536_bib16","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13073-023-01155-w","article-title":"The neuroimmune axis of Alzheimer's disease","volume":"15","author":"Jorfi","year":"2023","journal-title":"Genome Med"},{"key":"10.1016\/j.neurot.2025.e00536_bib17","article-title":"Whole exome sequencing study identifies novel rare and common Alzheimer\u2019s-Associated variants involved in immune response and transcriptional regulation","author":"Jian","year":"2018","journal-title":"Mol Psychiatr"},{"key":"10.1016\/j.neurot.2025.e00536_bib18","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/ng.3916","article-title":"Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer\u2019s disease","volume":"49","author":"Sims","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.neurot.2025.e00536_bib19","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/ng.803","article-title":"Common variants at ABCA7, MS4A6A\/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer\u2019s disease","volume":"43","author":"Hollingworth","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.neurot.2025.e00536_bib20","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1084\/jem.20190980","article-title":"Microglia drive APOE-dependent neurodegeneration in a tauopathy mouse model","volume":"216","author":"Shi","year":"2019","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.neurot.2025.e00536_bib21","doi-asserted-by":"crossref","first-page":"11524","DOI":"10.1073\/pnas.1710311114","article-title":"TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy","volume":"114","author":"Leyns","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neurot.2025.e00536_bib22","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1523\/JNEUROSCI.2939-14.2015","article-title":"SIRT1 deficiency in microglia contributes to cognitive decline in aging and neurodegeneration via epigenetic regulation of IL-1beta","volume":"35","author":"Cho","year":"2015","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.neurot.2025.e00536_bib23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neuron.2010.08.023","article-title":"Regulation of tau pathology by the microglial fractalkine receptor","volume":"68","author":"Bhaskar","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.neurot.2025.e00536_bib24","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/s41583-018-0055-7","article-title":"Inflammasome signalling in brain function and neurodegenerative disease","volume":"19","author":"Heneka","year":"2018","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.neurot.2025.e00536_bib25","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","article-title":"NLRP3 inflammasome activation drives tau pathology","volume":"575","author":"Ising","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.neurot.2025.e00536_bib26","first-page":"59","article-title":"Reevaluating the microbial infection link to Alzheimer's disease","volume":"73","author":"Schnaider","year":"2020","journal-title":"J\u00a0Alzheim Dis : JAD"},{"key":"10.1016\/j.neurot.2025.e00536_bib27","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/j.jalz.2018.06.3040","article-title":"The antimicrobial protection hypothesis of Alzheimer's disease","volume":"14","author":"Moir","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurot.2025.e00536_bib28","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neuron.2018.06.030","article-title":"Alzheimer\u2019s disease-associated \u03b2-amyloid is rapidly seeded by herpesviridae to protect against brain infection","volume":"99","author":"Eimer","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.neurot.2025.e00536_bib29","doi-asserted-by":"crossref","first-page":"340ra372","DOI":"10.1126\/scitranslmed.aaf1059","article-title":"Amyloid-\u03b2 peptide protects against microbial infection in mouse and worm models of Alzheimer\u2019s disease","volume":"8","author":"Kumar","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.neurot.2025.e00536_bib30","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1172\/JCI133737","article-title":"Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease","volume":"130","author":"Roy","year":"2020","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.neurot.2025.e00536_bib31","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1172\/JCI135906","article-title":"Intrinsic antiviral immunity drives neurodegeneration in Alzheimer disease","volume":"130","author":"Pluchino","year":"2020","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.neurot.2025.e00536_bib32","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12974-019-1417-4","article-title":"Anti-inflammatory and cognitive effects of interferon-\u03b21a (IFN\u03b21a) in a rat model of Alzheimer\u2019s disease","volume":"16","author":"Mud\u00f2","year":"2019","journal-title":"J\u00a0Neuroinflammation"},{"key":"10.1016\/j.neurot.2025.e00536_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2019.109661","article-title":"Interferon beta ameliorates cognitive dysfunction in a rat model of Alzheimer's disease: modulation of hippocampal neurogenesis and apoptosis as underlying mechanism","volume":"94","author":"Chavoshinezhad","year":"2019","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.neurot.2025.e00536_bib34","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.4049\/jimmunol.1601909","article-title":"Nonspecific DNA binding of cGAS N terminus promotes cGAS activation","volume":"198","author":"Tao","year":"2017","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.neurot.2025.e00536_bib35","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nsmb.2332","article-title":"Crystal structures of STING protein reveal basis for recognition of cyclic di-GMP","volume":"19","author":"Shang","year":"2012","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.neurot.2025.e00536_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.808607","article-title":"Activation of STING based on its structural features","volume":"13","author":"Hussain","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.neurot.2025.e00536_bib37","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neulet.2017.08.039","article-title":"Human microglia and astrocytes express cGAS-STING viral sensing components","volume":"658","author":"Jeffries","year":"2017","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurot.2025.e00536_bib38","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s41593-023-01315-6","article-title":"Tau activation of microglial cGAS\u2013IFN reduces MEF2C-mediated cognitive resilience","volume":"26","author":"Udeochu","year":"2023","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neurot.2025.e00536_bib39","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13024-023-00672-x","article-title":"Mechanism and therapeutic potential of targeting cGAS-STING signaling in neurological disorders","volume":"18","author":"Huang","year":"2023","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.neurot.2025.e00536_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24098151","article-title":"Role of cGAS-sting signaling in Alzheimer\u2019s disease","volume":"24","author":"Govindarajulu","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neurot.2025.e00536_bib42","doi-asserted-by":"crossref","unstructured":"Carling, G. K. et\u00a0al. Alzheimer's disease-linked risk alleles elevate microglial cGAS-associated senescence and neurodegeneration in a tauopathy model. Neuron, https:\/\/doi.org\/10.1016\/j.neuron.2024.09.006.","DOI":"10.1016\/j.neuron.2024.09.006"},{"key":"10.1016\/j.neurot.2025.e00536_bib43","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.cell.2018.06.026","article-title":"Structure of the human cGAS-DNA complex reveals enhanced control of immune surveillance","volume":"174","author":"Zhou","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.neurot.2025.e00536_bib45","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.immuni.2013.10.019","article-title":"Cyclic GMP-AMP synthase is activated by double-stranded DNA-induced oligomerization","volume":"39","author":"Li","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.neurot.2025.e00536_bib46","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.cytogfr.2014.06.006","article-title":"The mechanism of double-stranded DNA sensing through the cGAS-STING pathway","volume":"25","author":"Shu","year":"2014","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.neurot.2025.e00536_bib47","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1002\/pro.3304","article-title":"The catalytic mechanism of cyclic GMP-AMP synthase (cGAS) and implications for innate immunity and inhibition","volume":"26","author":"Hall","year":"2017","journal-title":"Protein Sci"},{"key":"10.1016\/j.neurot.2025.e00536_bib48","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.cell.2013.04.046","article-title":"Cyclic [G(2\u2019,5\u2019)pA(3\u2019,5\u2019)p] is the metazoan second messenger produced by DNA-activated cyclic GMP-AMP synthase","volume":"153","author":"Gao","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.neurot.2025.e00536_bib49","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.cell.2014.07.028","article-title":"Structure-guided reprogramming of human cGAS dinucleotide linkage specificity","volume":"158","author":"Kranzusch","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.neurot.2025.e00536_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00928361","article-title":"Physiological concentrations of purines and pyrimidines","volume":"140","author":"Traut","year":"1994","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.neurot.2025.e00536_bib51","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1126\/science.1232458","article-title":"Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway","volume":"339","author":"Sun","year":"2013","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.neurot.2025.e00536_bib52","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1126\/science.1229963","article-title":"Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA","volume":"339","author":"Wu","year":"2013","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.neurot.2025.e00536_bib53","doi-asserted-by":"crossref","first-page":"114791","DOI":"10.1016\/j.ejmech.2022.114791","article-title":"Medicinal chemistry perspective on cGAS-STING signaling pathway with small molecule inhibitors","volume":"244","author":"Tian","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.neurot.2025.e00536_bib54","doi-asserted-by":"crossref","first-page":"9375","DOI":"10.1021\/acs.jmedchem.9b00359","article-title":"Overview of recent strategic advances in medicinal chemistry","volume":"62","author":"Wu","year":"2019","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.neurot.2025.e00536_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.116614","article-title":"Structural modification aimed for improving solubility of lead compounds in early phase drug discovery","volume":"56","author":"Das","year":"2022","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.neurot.2025.e00536_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.655637","article-title":"Perillaldehyde inhibition of cGAS reduces dsDNA-induced interferon response","volume":"12","author":"Chu","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.neurot.2025.e00536_bib57","doi-asserted-by":"crossref","first-page":"6082","DOI":"10.1093\/nar\/gkab451","article-title":"Sequence-dependent inhibition of cGAS and TLR9 DNA sensing by 2\u2032-O-methyl gapmer oligonucleotides","volume":"49","author":"Valentin","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.neurot.2025.e00536_bib58","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1016\/j.apsb.2020.03.001","article-title":"Small molecules targeting the innate immune cGAS\u2012STING\u2012TBK1 signaling pathway","volume":"10","author":"Ding","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.neurot.2025.e00536_bib60","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1080\/13543776.2022.2144220","article-title":"Recent advances in the development of STING inhibitors: an updated patent review","volume":"32","author":"Shen","year":"2022","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.neurot.2025.e00536_bib61","article-title":"Agonists and inhibitors of the cGAS-STING pathway","volume":"29","author":"Yu","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.neurot.2025.e00536_bib62","doi-asserted-by":"crossref","first-page":"6132","DOI":"10.1038\/s41467-023-41892-5","article-title":"Development of cyclopeptide inhibitors of cGAS targeting protein-DNA interaction and phase separation","volume":"14","author":"Wang","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.neurot.2025.e00536_bib63","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.4155\/fmc-2017-0322","article-title":"Suramin potently inhibits cGAMP synthase, cGAS, in THP1 cells to modulate IFN-\u03b2 levels","volume":"10","author":"Wang","year":"2018","journal-title":"Future Med Chem"},{"key":"10.1016\/j.neurot.2025.e00536_bib65","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.4049\/jimmunol.1402793","article-title":"Cutting edge: antimalarial drugs inhibit IFN-\u03b2 production through blockade of cyclic GMP-AMP synthase-DNA interaction","volume":"194","author":"An","year":"2015","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.neurot.2025.e00536_bib66","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1038\/s41467-019-08620-4","article-title":"Development of human cGAS-specific small-molecule inhibitors for repression of dsDNA-triggered interferon expression","volume":"10","author":"Lama","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.neurot.2025.e00536_bib67","article-title":"2,3,4,5-TETRAHYDRO-1H-PYRIDO[4, 3-B]indole inhibitors of CGAS for treating autoinflammatory diseases","author":"Lama","year":"2019","journal-title":"WO patent WO 2019\/153002 A1"},{"key":"10.1016\/j.neurot.2025.e00536_bib68","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1089\/154065804323056495","article-title":"High-throughput screening with quantitation of ATP consumption: a universal non-radioisotope, homogeneous assay for protein kinase","volume":"2","author":"Koresawa","year":"2004","journal-title":"Assay Drug Dev Technol"},{"key":"10.1016\/j.neurot.2025.e00536_bib69","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114850","article-title":"Advances in high-throughput mass spectrometry in drug discovery","volume":"15","author":"Due\u00f1as","year":"2023","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.neurot.2025.e00536_bib70","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1021\/acsmedchemlett.0c00314","article-title":"Emerging chromatography-free high-throughput mass spectrometry technologies for generating hits and leads","volume":"11","author":"Pu","year":"2020","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.neurot.2025.e00536_bib71","first-page":"77","volume":"vol. 625","author":"Hooy","year":"2019"},{"key":"10.1016\/j.neurot.2025.e00536_bib72","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/s41467-017-00833-9","article-title":"Small molecule inhibition of cGAS reduces interferon expression in primary macrophages from autoimmune mice","volume":"8","author":"Vincent","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.neurot.2025.e00536_bib73","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1021\/acs.jcim.0c00113","article-title":"Augmenting hit identification by virtual screening techniques in small molecule drug discovery","volume":"60","author":"Yan","year":"2020","journal-title":"J\u00a0Chem Inf Model"},{"key":"10.1016\/j.neurot.2025.e00536_bib74","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1021\/ci200528d","article-title":"Recognizing pitfalls in virtual screening: a critical review","volume":"52","author":"Scior","year":"2012","journal-title":"J\u00a0Chem Inf Model"},{"key":"10.1016\/j.neurot.2025.e00536_bib75","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/cbdd.14116","article-title":"DNA intercalators as anticancer agents","volume":"100","author":"Venugopal","year":"2022","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.neurot.2025.e00536_bib76","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1177\/1087057114520973","article-title":"Assay development and high-throughput screening for inhibitors of kaposi's sarcoma-associated herpesvirus N-Terminal latency-associated nuclear Antigen binding to nucleosomes","volume":"19","author":"Beauchemin","year":"2014","journal-title":"J\u00a0Biomol Screen"},{"key":"10.1016\/j.neurot.2025.e00536_bib77","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1146\/annurev-med-043015-123453","article-title":"Antimalarial drugs as immune modulators: new mechanisms for old drugs","volume":"68","author":"An","year":"2017","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.neurot.2025.e00536_bib78","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1002\/art.40559","article-title":"Inhibition of cyclic GMP-AMP synthase using a novel antimalarial drug derivative in Trex1-Deficient mice","volume":"70","author":"An","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.neurot.2025.e00536_bib81","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/s41401-022-01002-5","article-title":"Discovery and characterization of a novel cGAS covalent inhibitor for the treatment of inflammatory bowel disease","volume":"44","author":"Song","year":"2023","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.neurot.2025.e00536_bib82","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184843","article-title":"Discovery of PF-06928215 as a high affinity inhibitor of cGAS enabled by a novel fluorescence polarization assay","volume":"12","author":"Hall","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.neurot.2025.e00536_bib84","article-title":"Inhibitors of cGAS for treating autoinflammatory diseases and cancer metastasis","author":"Tomita","year":"2020","journal-title":"WO patent WO 2020\/186027 A1"},{"key":"10.1016\/j.neurot.2025.e00536_bib85","article-title":"PYRIDO[4,3-b]INDOLE derivatives and their use as pharmaceuticals","author":"Fader","year":"2022","journal-title":"WO patent WO 2022\/066851 A1"},{"key":"10.1016\/j.neurot.2025.e00536_bib86","article-title":"HEXAHYDROPYRIDO[4,3-B]INDOLYL ketone derivatives useful as CGAS modulators","author":"Beveridge","year":"2023","journal-title":"WO patent WO 2023\/183275 A1"},{"key":"10.1016\/j.neurot.2025.e00536_bib87","doi-asserted-by":"crossref","first-page":"7667","DOI":"10.1021\/acs.jmedchem.1c00398","article-title":"Synthesis and pharmacological evaluation of tetrahydro-\u03b3-carboline derivatives as potent anti-inflammatory agents targeting cyclic GMP\u2013AMP synthase","volume":"64","author":"Tan","year":"2021","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.neurot.2025.e00536_bib88","doi-asserted-by":"crossref","first-page":"6268","DOI":"10.1021\/acs.jmedchem.3c02229","article-title":"Design, synthesis, and pharmacological evaluation of spiro[carbazole-3,3\u2032-pyrrolidine] derivatives as cGAS inhibitors for treatment of acute Lung Injury","volume":"67","author":"Chen","year":"2024","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.neurot.2025.e00536_bib89","article-title":"CGAS Inhibitors","author":"Ahmed","year":"2023","journal-title":"WO patent WO 2023\/235809 A1"},{"key":"10.1016\/j.neurot.2025.e00536_bib90","article-title":"Cgas inhibitors and uses thereof","author":"Sinha","year":"2023","journal-title":"WO patent WO 2023\/154962 A1"},{"key":"10.1016\/j.neurot.2025.e00536_bib91","article-title":"Inhibitors of CGAS activity as therapeutic agents","author":"Lowery Robert","year":"2020","journal-title":"WO patent WO 2020\/142735 A1"},{"key":"10.1016\/j.neurot.2025.e00536_bib92","article-title":"Inhibitors of cGAS activity as therapeutic agents","author":"Lowery","year":"2024","journal-title":"WO patent WO 2024\/035622 A1"},{"key":"10.1016\/j.neurot.2025.e00536_bib93","article-title":"Pyridine derivatives with N-linked cyclic substituents as CGAS inhibitors","author":"Heimann Annekatrin","year":"2022","journal-title":"WO patent WO 2022\/238327 A1"},{"key":"10.1016\/j.neurot.2025.e00536_bib94","article-title":"Heterocyclic compounds and uses thereof","author":"Beveridge","year":"2023","journal-title":"WO patent WO 2023\/081441 A1"},{"key":"10.1016\/j.neurot.2025.e00536_bib95","article-title":"Thiadiazole derivatives as inhibitors of cyclic GMP-AMP synthase and uses thereof","author":"Beveridge","year":"2024","journal-title":"WO patent WO 2024\/137607 A1"},{"key":"10.1016\/j.neurot.2025.e00536_bib96","article-title":"cGAS antagonist compounds","author":"Zhong","year":"2017","journal-title":"WO patent WO 2017\/176812 A1"},{"key":"10.1016\/j.neurot.2025.e00536_bib97","article-title":"Sulfamoylamide derivatives","author":"Berchtold","year":"2021","journal-title":"WO patent WO 2021\/209475 A1"},{"key":"10.1016\/j.neurot.2025.e00536_bib98","article-title":"Indazole derivatives","author":"Berchtold","year":"2021","journal-title":"WO patent WO 2021\/209481 A1"},{"key":"10.1016\/j.neurot.2025.e00536_bib99","article-title":"Biphenyl derivatives","author":"Berchtold","year":"2021","journal-title":"WO patent WO 2021\/209473 A1"},{"key":"10.1016\/j.neurot.2025.e00536_bib100","article-title":"Benzimidazole derivatives","author":"Galley","year":"2021","journal-title":"WO patent WO 2021\/209484 A1"},{"key":"10.1016\/j.neurot.2025.e00536_bib101","article-title":"New malonitrile derivatives","author":"D\u00e9coret","year":"2021","journal-title":"WO patent WO 2021\/233854 A1"},{"key":"10.1016\/j.neurot.2025.e00536_bib102","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1021\/acs.joc.9b02666","article-title":"Discovery of small-molecule cyclic GMP-AMP synthase inhibitors","volume":"85","author":"Padilla-Salinas","year":"2020","journal-title":"J\u00a0Org Chem"},{"key":"10.1016\/j.neurot.2025.e00536_bib103","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1021\/acs.jcim.0c00171","article-title":"In silico screening-based discovery of novel inhibitors of human cyclic GMP\u2013AMP synthase: a cross-validation study of molecular docking and experimental testing","volume":"60","author":"Zhao","year":"2020","journal-title":"J\u00a0Chem Inf Model"},{"key":"10.1016\/j.neurot.2025.e00536_bib104","doi-asserted-by":"crossref","first-page":"106802","DOI":"10.1016\/j.bioorg.2023.106802","article-title":"Discovery of novel cGAS inhibitors based on natural flavonoids","volume":"140","author":"Li","year":"2023","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.neurot.2025.e00536_bib105","series-title":"Rscb PDB","year":"2024"},{"key":"10.1016\/j.neurot.2025.e00536_bib106","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.cell.2019.01.016","article-title":"Acetylation blocks cGAS activity and inhibits self-DNA-induced autoimmunity","volume":"176","author":"Dai","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.neurot.2025.e00536_bib107","doi-asserted-by":"crossref","first-page":"21568","DOI":"10.1073\/pnas.1922330117","article-title":"KAT5 acetylates cGAS to promote innate immune response to DNA virus","volume":"117","author":"Song","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neurot.2025.e00536_bib108","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41586-018-0629-6","article-title":"Nuclear cGAS suppresses DNA repair and promotes tumorigenesis","volume":"563","author":"Liu","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.neurot.2025.e00536_bib109","first-page":"371","article-title":"Phosphorylation and chromatin tethering prevent cGAS activation during mitosis","author":"Li","year":"2021","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.neurot.2025.e00536_bib110","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s13238-020-00729-3","article-title":"Dephosphorylation of cGAS by PPP6C impairs its substrate binding activity and innate antiviral response","volume":"11","author":"Li","year":"2020","journal-title":"Protein Cell"},{"key":"10.1016\/j.neurot.2025.e00536_bib111","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1038\/s41467-020-19941-0","article-title":"DNA-PK deficiency potentiates cGAS-mediated antiviral innate immunity","volume":"11","author":"Sun","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.neurot.2025.e00536_bib112","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.celrep.2015.09.007","article-title":"Akt kinase-mediated checkpoint of cGAS DNA sensing pathway","volume":"13","author":"Seo","year":"2015","journal-title":"Cell Rep"},{"key":"10.1016\/j.neurot.2025.e00536_bib113","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41421-020-0162-2","article-title":"Phosphorylation of cGAS by CDK1 impairs self-DNA sensing in mitosis","volume":"6","author":"Zhong","year":"2020","journal-title":"Cell Discov"},{"key":"10.1016\/j.neurot.2025.e00536_bib114","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.molcel.2016.08.025","article-title":"TRIM14 inhibits cGAS degradation mediated by selective autophagy receptor p62 to promote innate immune responses","volume":"64","author":"Chen","year":"2016","journal-title":"Mol Cell"},{"key":"10.1016\/j.neurot.2025.e00536_bib115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006264","article-title":"The E3 ubiquitin ligase RNF185 facilitates the cGAS-mediated innate immune response","volume":"13","author":"Wang","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.neurot.2025.e00536_bib116","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41467-018-02936-3","article-title":"TRIM56-mediated monoubiquitination of cGAS for cytosolic DNA sensing","volume":"9","author":"Seo","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.neurot.2025.e00536_bib117","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13578-018-0233-3","article-title":"RINCK-mediated monoubiquitination of cGAS promotes antiviral innate immune responses","volume":"8","author":"Liu","year":"2018","journal-title":"Cell Biosci"},{"key":"10.1016\/j.neurot.2025.e00536_bib118","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.4049\/jimmunol.1900514","article-title":"Cutting edge: USP27X deubiquitinates and stabilizes the DNA sensor cGAS to regulate cytosolic DNA-mediated signaling","volume":"203","author":"Guo","year":"2019","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.neurot.2025.e00536_bib119","doi-asserted-by":"crossref","first-page":"eabk3067","DOI":"10.1126\/scisignal.abk3067","article-title":"MARCH8 attenuates cGAS-mediated innate immune responses through ubiquitylation","volume":"15","author":"Yang","year":"2022","journal-title":"Sci Signal"},{"key":"10.1016\/j.neurot.2025.e00536_bib120","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.immuni.2016.08.014","article-title":"Sumoylation promotes the stability of the DNA sensor cGAS and the adaptor STING to regulate the kinetics of response to DNA virus","volume":"45","author":"Hu","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.neurot.2025.e00536_bib121","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006156","article-title":"SENP7 potentiates cGAS activation by relieving SUMO-mediated inhibition of cytosolic DNA sensing","volume":"13","author":"Cui","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.neurot.2025.e00536_bib122","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41413-022-00194-0","article-title":"RIOX1-demethylated cGAS regulates ionizing radiation-elicited DNA repair","volume":"10","author":"Xiao","year":"2022","journal-title":"Bone Res"},{"key":"10.1016\/j.neurot.2025.e00536_bib123","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021109272","article-title":"ZDHHC18 negatively regulates cGAS-mediated innate immunity through palmitoylation","volume":"41","author":"Shi","year":"2022","journal-title":"EMBO J"},{"key":"10.1016\/j.neurot.2025.e00536_bib124","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1016\/j.molcel.2023.09.007","article-title":"Targeting LYPLAL1-mediated cGAS depalmitoylation enhances the response to anti-tumor immunotherapy","volume":"83","author":"Fan","year":"2023","journal-title":"Mol Cell"},{"key":"10.1016\/j.neurot.2025.e00536_bib125","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/ni.3356","article-title":"Glutamylation of the DNA sensor cGAS regulates its binding and synthase activity in antiviral immunity","volume":"17","author":"Xia","year":"2016","journal-title":"Nat Immunol"},{"key":"10.1016\/j.neurot.2025.e00536_bib126","doi-asserted-by":"crossref","first-page":"7842","DOI":"10.3390\/ijms21217842","article-title":"Role of post-translational modifications of cGAS in innate immunity","volume":"21","author":"Wu","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neurot.2025.e00536_bib127","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.3390\/cells11193043","article-title":"Post-translational modifications of cGAS-STING: a critical switch for immune regulation","volume":"11","author":"Yu","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.neurot.2025.e00536_bib128","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.chom.2018.07.004","article-title":"Species-specific deamidation of cGAS by herpes simplex virus UL37 protein facilitates viral replication","volume":"24","author":"Zhang","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.neurot.2025.e00536_bib129","first-page":"163","volume":"vol. 109","author":"Song","year":"2021"},{"key":"10.1016\/j.neurot.2025.e00536_bib130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.molcel.2019.02.013","article-title":"Apoptotic caspases suppress type I interferon production via the cleavage of cGAS, MAVS, and IRF3","volume":"74","author":"Ning","year":"2019","journal-title":"Mol Cell"},{"key":"10.1016\/j.neurot.2025.e00536_bib131","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.immuni.2017.02.011","article-title":"Inflammasome activation triggers caspase-1-mediated cleavage of cGAS to regulate responses to DNA virus infection","volume":"46","author":"Wang","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.neurot.2025.e00536_bib132","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202050051","article-title":"Autoimmunity gene IRGM suppresses cGAS-STING and RIG-I-MAVS signaling to control interferon response","volume":"21","author":"Jena","year":"2020","journal-title":"EMBO Rep"},{"key":"10.1016\/j.neurot.2025.e00536_bib133","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1080\/17568919.2024.2383164","article-title":"Protein-protein interactions in cGAS-STING pathway: a medicinal chemistry perspective","volume":"16","author":"Zhang","year":"2024","journal-title":"Future Med Chem"},{"key":"10.1016\/j.neurot.2025.e00536_bib134","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s43587-022-00337-2","article-title":"Activation of innate immune cGAS-STING pathway contributes to Alzheimer\u2019s pathogenesis in 5\u00d7FAD mice","volume":"3","author":"Xie","year":"2023","journal-title":"Nat Aging"},{"key":"10.1016\/j.neurot.2025.e00536_bib136","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1038\/s12276-024-01295-y","article-title":"Blockade of STING activation alleviates microglial dysfunction and a broad spectrum of Alzheimer\u2019s disease pathologies","volume":"56","author":"Chung","year":"2024","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.neurot.2025.e00536_bib137","article-title":"APOE3-R136S mutation confers resilience against tau pathology via cGAS-STING-IFN inhibition","author":"Naguib","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.neurot.2025.e00536_bib138","doi-asserted-by":"crossref","first-page":"175809","DOI":"10.1016\/j.ejphar.2023.175809","article-title":"Tetrahydroxy stilbene glycoside ameliorates neuroinflammation for Alzheimer\u2019s disease via cGAS-STING","volume":"953","author":"Gao","year":"2023","journal-title":"Eur J Pharmacol"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925000145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925000145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T13:26:00Z","timestamp":1744723560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747925000145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":130,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1878747925000145"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00536","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification and development of cGAS inhibitors and their uses to treat Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00536","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00536"}}